Overexpression of helper T cell type 2-related molecules in the skin of patients with eosinophilic dermatosis of hematologic malignancy.


Journal

Journal of the American Academy of Dermatology
ISSN: 1097-6787
Titre abrégé: J Am Acad Dermatol
Pays: United States
ID NLM: 7907132

Informations de publication

Date de publication:
10 2022
Historique:
received: 27 01 2021
revised: 16 06 2021
accepted: 04 07 2021
pubmed: 16 7 2021
medline: 21 9 2022
entrez: 15 7 2021
Statut: ppublish

Résumé

Eosinophilic dermatosis of hematologic malignancy (EDHM) is a rare dermatosis associated with blood tumors. To characterize the expression of T-cell and B-cell markers and pruritogenic mediators in EDHM skin. Immunohistochemical and immunofluorescence analysis were performed in 12 skin samples of EDHM, 11 samples of bullous pemphigoid (BP), and 5 samples from healthy controls (HC). Serum levels of interleukin (IL) 4 were analyzed in 11 patients with EDHM, 11 BP patients, and 5 HC by enzyme-linked immunosorbent assay. T-cell markers, including clusters of differentiation (CD) 3, CD4, CD8, and CD5 were significantly overexpressed in EDHM and BP skin compared to HC. A predominance of CD4 Small sample size; retrospective design. Targeting Th2-related molecules, in particular IL-4, holds promise for EDHM management.

Sections du résumé

BACKGROUND
Eosinophilic dermatosis of hematologic malignancy (EDHM) is a rare dermatosis associated with blood tumors.
OBJECTIVE
To characterize the expression of T-cell and B-cell markers and pruritogenic mediators in EDHM skin.
METHODS
Immunohistochemical and immunofluorescence analysis were performed in 12 skin samples of EDHM, 11 samples of bullous pemphigoid (BP), and 5 samples from healthy controls (HC). Serum levels of interleukin (IL) 4 were analyzed in 11 patients with EDHM, 11 BP patients, and 5 HC by enzyme-linked immunosorbent assay.
RESULTS
T-cell markers, including clusters of differentiation (CD) 3, CD4, CD8, and CD5 were significantly overexpressed in EDHM and BP skin compared to HC. A predominance of CD4
LIMITATIONS
Small sample size; retrospective design.
CONCLUSIONS
Targeting Th2-related molecules, in particular IL-4, holds promise for EDHM management.

Identifiants

pubmed: 34265409
pii: S0190-9622(21)02090-9
doi: 10.1016/j.jaad.2021.07.007
pii:
doi:

Substances chimiques

Chemokine CCL11 0
Forkhead Transcription Factors 0
Interleukins 0
Interleukin-4 207137-56-2

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

761-770

Informations de copyright

Copyright © 2021 American Academy of Dermatology, Inc. Published by Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Conflicts of interest None disclosed.

Auteurs

Roberto Maglie (R)

Department of Health Sciences, Section of Dermatology, University of Florence, Florence, Italy. Electronic address: robertomaglie.med@libero.it.

Filippo Ugolini (F)

Department of Health Sciences, Section of Pathological Anatomy, University of Florence, Florence, Italy.

Francesco De Logu (F)

Department of Health Sciences, Section of Clinical Pharmacology and Oncology, University of Florence, Florence, Italy.

Romina Nassini (R)

Department of Health Sciences, Section of Clinical Pharmacology and Oncology, University of Florence, Florence, Italy.

Sara Simi (S)

Department of Health Sciences, Section of Pathological Anatomy, University of Florence, Florence, Italy.

Pamela Nardiello (P)

Department of Health Sciences, Section of Pathological Anatomy, University of Florence, Florence, Italy.

Elisa Pasqualini (E)

Department of Health Sciences, Section of Pathological Anatomy, University of Florence, Florence, Italy.

Gianna Baroni (G)

Department of Health Sciences, Section of Pathological Anatomy, University of Florence, Florence, Italy.

Elena Del Bianco (E)

Department of Health Sciences, Section of Dermatology, University of Florence, Florence, Italy.

Daniela Massi (D)

Department of Health Sciences, Section of Pathological Anatomy, University of Florence, Florence, Italy.

Emiliano Antiga (E)

Department of Health Sciences, Section of Dermatology, University of Florence, Florence, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH